CUTIA-B: VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF CU-20401 (RECOMBINANT MUTANTCOLLAGENASE) FOR SUBMENTAL ADIPOSE ACCUMULATION REACHED PRIMARY ENDPOINT

HKEX · Nov 29, 2024 06:07

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.